Testing TcMS to stop dangerous fast heart rhythms
Part of Heart & circulation clinical trials.
This trial tests a treatment called TcMS to reduce episodes of dangerous fast heart rhythm (VT) or shocks from an implanted heart device. It may help people who keep having these episodes even after taking at least one anti-arrhythmia medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’ve had at least 3 episodes of sustained VT, or your ICD gave an appropriate therapy, within 24 hours
- You’re already taking at least one anti-arrhythmia medicine, and it hasn’t fully prevented the episodes
- You do not plan to get catheter ablation for VT within the next 24 hours
- You are not pregnant
- You don’t have certain implanted devices/metal or medical conditions that make TcMS unsafe for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two catheter-based procedures to treat ventricular tachycardia (VT), a fast, dangerous heart rhythm. It looks to see which approach works better at reducing repeat VT events in people with weakened heart pumping.
This study tests a heart procedure (catheter ablation) to stop dangerous, fast heart rhythms (electrical storm) in people with weakened heart muscle. The goal is to see if the procedure can safely control these rhythms when blood pressure drops dangerously low.
This trial tests a new catheter-based procedure to treat life-threatening irregular heartbeats (ventricular tachycardia) that keep coming back despite medication. If you've had a heart attack and your implanted defibrillator hasn't fully controlled these arrhythmias, this procedure might help prevent future episodes.
This trial compares two treatments—radiation therapy or catheter ablation—for people with structural heart disease who have a type of fast heart rhythm called ventricular tachycardia. It aims to see which approach works better to prevent repeat episodes.
This trial studies a heart rhythm procedure (“ablation”) for people with ischemic cardiomyopathy who have ongoing episodes of sustained ventricular tachycardia. It aims to reduce these dangerous rhythm events, especially when standard anti-rhythm medications don’t work or can’t be used.
This trial is testing a new approach to treating a fast, dangerous heart rhythm (ventricular tachycardia) that comes from scar tissue in people with ischemic cardiomyopathy. The goal is to use a special mapping technique to guide the ablation (a procedure that destroys the tiny area causing the problem) to stop the arrhythmia.
Hear when a new Ventricular Tachycardia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.